About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Schizophrenia Clinical Trials | 4,235 Studies Recruiting

Clinical TrialsSchizophrenia

Schizophrenia Clinical Trials

Browse 4,235 clinical trials for schizophrenia. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2541-2560 of 4,235 trials

RecruitingEarly Identification of Patients Presenting a First Psychotic Episode, Non Answering to First Line Support StrategiesResearchers propose in this project to evaluate predictive factors of non response.NCT02670447·Bron and 4 others CompletedMetformin for the Prevention of the Metabolic Side-effects of ZyprexaWe hypothesize that metformin co-administered with olanzapine will be well tolerated and associated with significantly less insulin resistance, weight gain and dyslipidemia as…NCT00682448·Chicago, Illinois CompletedCognitive Remediation Therapy for Participants With Late-Life SchizophreniaCognitive Remediation (CR) involving restorative and strategy-based methods has been previously validated in a pilot study for late life schizophrenia (LLS), where CR demonstrated…NCT03695614·Toronto, Ontario

Related Searches

Data from ClinicalTrials.govTerms

CompletedMulti-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in PsychosisThe purpose of this study is to better understand mental illness and will test the hypotheses that, while viewing affective stimuli, patient groups will show increased blood…NCT04004416·Ann Arbor, Michigan

CompletedAmisulpride Augmentation in Clozapine-unresponsive SchizophreniaSchizophrenia is a mental health problem usually starting in the late teens/early twenties, and often lasting many years.NCT01246232·London and 2 others

CompletedBariatric Surgery in Patients With SchizophreniaIt is known that schizophrenia is associated with obesity in a significant number of patients and it implies a poor prognostic factor, with weight loss being important in this…NCT06043206·Barcelona

CompletedInjectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI)The overall goal of this project is to improve the treatment of alcohol dependence in patients with serious mental illness (SMI).NCT00453609·Syracuse, New York and 2 others

CompletedStudy of Amantadine for Weight Stabilization During Olanzapine TreatmentWeight gain associated with antipsychotic medication use is a major side effect that limits the tolerability of these drugs.NCT00287352·Chapel Hill, North Carolina

CompletedBrain Stimulation and Cognitive Training - EfficacyPeople with serious mental illness often experience difficulties with thinking skills like memory. These difficulties can make it harder to perform day-to-day activities.NCT05111548·Ann Arbor, Michigan

CompletedTargeting a Genetic Mutation in Glycine Metabolism With D-cycloserineThe purpose of this study is to assess the efficacy of d-cycloserine (DCS) as an augmentation strategy in two psychotic patients with a triplication (4 copies) of the glycine…NCT02304432

CompletedEffects of Antipsychotics on Eating and Food Craving in People With SchizophreniaBackground: \- Although second-generation antipsychotic medications have fewer serious side effects and complications than first-generation ones, they are strongly associated…NCT01222793·Baltimore, Maryland

CompletedEvaluation of the In SHAPE Fitness Intervention for Adults With Serious Mental IllnessFew studies targeting obesity in serious mental illness have reported clinically significant risk reduction, and non have been replicated in community settings or demonstrated…NCT02334228·Concord, New Hampshire

TerminatedMemantine for the Treatment of Cognitive Dysfunction and Negative Symptoms in Patients With Chronic SchizophreniaThe purpose of this study is to evaluate the efficacy and safety of 24 weeks memantine add-on treatment to risperidone for the treatment of negative symptomatology and cognitive…NCT00148616·Berlin

CompletedLong-Acting Injectable Risperidone in the Treatment of SchizophreniaIn the proposed study 450 veterans with a primary diagnosis of schizophrenia who had at least one psychiatric hospitalization for schizophrenia in the previous 2 years would be…NCT00132314·Tuscaloosa, Alabama and 18 others

CompletedTreatment of Behavioral Symptoms in Alzheimer's DiseaseThe optimal strategy for the treatment of behavioral complications in patients with probable Alzheimer's disease (AD) remains unclear.NCT00009217·New York, New York

CompletedNurse-led Psycho-education Program for People With First-onset Mental Illness (APN-PEP)The study aims to test the effectiveness of a nurse-led psycho-education program based on motivational interviewing technique for Chinese patients with first-onset mental illness…NCT02275390·Tai Po, New Territories and 1 other

CompletedAripiprazole in Patients With Psychosis Associated With Parkinson's DiseaseThe purpose of this clinical research study is to assess the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease.NCT00095810·Albany, New York

CompletedV3: Vancouver-Victoria Valacyclovir Trial for Early PsychosisThis is an 18 week (2 weeks run-in, 16 weeks double blind) trial, to determine if an antiviral drug, valacyclovir (Valtrex) is helpful in treating the symptoms of psychosis, a…NCT00175513·Victoria, British Columbia and 1 other

CompletedMetabolic Effects of Melatonin in Patients Treated With Second Generation AntipsychoticsSchizophrenia and bipolar disorder are frequently associated with an elevated risk for obesity, metabolic syndrome, diabetes mellitus, dyslipidemia and other metabolic…NCT01811160·Mexico City, México City

CompletedModafinil for Treatment of Cognitive Dysfunction in SchizophreniaPatients with schizophrenia have problems in thinking, known as cognitive dysfunction. This appears to be responsible for their difficulties in social and occupational functioning.NCT00423943·Los Angeles, California

PreviousPage 128 of 212Next